JP2008013542A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008013542A5 JP2008013542A5 JP2007138744A JP2007138744A JP2008013542A5 JP 2008013542 A5 JP2008013542 A5 JP 2008013542A5 JP 2007138744 A JP2007138744 A JP 2007138744A JP 2007138744 A JP2007138744 A JP 2007138744A JP 2008013542 A5 JP2008013542 A5 JP 2008013542A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- bromhexine
- ambroxol
- loxoprofen
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 claims 6
- 229960002373 loxoprofen Drugs 0.000 claims 6
- 229960005174 ambroxol Drugs 0.000 claims 5
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 claims 5
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 claims 5
- 229960003870 bromhexine Drugs 0.000 claims 5
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 229960000985 ambroxol hydrochloride Drugs 0.000 claims 1
- 229960002335 bromhexine hydrochloride Drugs 0.000 claims 1
- YRSGDLIATOURQO-UHFFFAOYSA-N ethyl 4-acetyl-5-oxohexanoate Chemical group CCOC(=O)CCC(C(C)=O)C(C)=O YRSGDLIATOURQO-UHFFFAOYSA-N 0.000 claims 1
- 210000002175 goblet cell Anatomy 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007138744A JP2008013542A (ja) | 2006-06-07 | 2007-05-25 | 去痰又は気道杯細胞過形成抑制のための医薬組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006158130 | 2006-06-07 | ||
| JP2007138744A JP2008013542A (ja) | 2006-06-07 | 2007-05-25 | 去痰又は気道杯細胞過形成抑制のための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008013542A JP2008013542A (ja) | 2008-01-24 |
| JP2008013542A5 true JP2008013542A5 (enExample) | 2010-06-24 |
Family
ID=39070910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007138744A Pending JP2008013542A (ja) | 2006-06-07 | 2007-05-25 | 去痰又は気道杯細胞過形成抑制のための医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008013542A (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010168373A (ja) * | 2008-12-25 | 2010-08-05 | Kowa Co | ロキソプロフェン含有医薬組成物 |
| JP2010215611A (ja) * | 2009-01-28 | 2010-09-30 | Kowa Co | ロキソプロフェン含有医薬製剤 |
| JP5624367B2 (ja) * | 2009-05-28 | 2014-11-12 | 興和株式会社 | ロキソプロフェン含有医薬製剤 |
| JP5798735B2 (ja) * | 2009-10-30 | 2015-10-21 | 興和株式会社 | ロキソプロフェン含有医薬組成物 |
| JP5897804B2 (ja) * | 2010-02-26 | 2016-03-30 | 興和株式会社 | ロキソプロフェン含有の医薬組成物 |
| JP2012106977A (ja) * | 2010-05-31 | 2012-06-07 | Kowa Co | ロキソプロフェンを含有する医薬組成物 |
| DK2593094T3 (en) * | 2010-07-12 | 2018-03-12 | Sanofi Aventis Deutschland | AUTHENTIC COMPOSITION CONTAINING BROMHEXIN |
| JP5999892B2 (ja) * | 2010-12-16 | 2016-09-28 | 第一三共ヘルスケア株式会社 | ロキソプロフェンナトリウムとブロムヘキシンを含有する固形製剤 |
| JP6008857B2 (ja) * | 2011-07-29 | 2016-10-19 | 興和株式会社 | ロキソプロフェンを含有する医薬組成物 |
| JP2016135745A (ja) * | 2014-01-20 | 2016-07-28 | 興和株式会社 | ロキソプロフェン含有去痰医薬組成物 |
| CA2949882C (en) * | 2014-05-23 | 2023-02-28 | Boehringer Ingelheim International Gmbh | Cough syrup containing ambroxol hydrochloride |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001172175A (ja) * | 1999-12-14 | 2001-06-26 | Taisho Pharmaceut Co Ltd | 風邪用組成物 |
-
2007
- 2007-05-25 JP JP2007138744A patent/JP2008013542A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008013542A5 (enExample) | ||
| FIC20230040I1 (fi) | Koostumus käsittäen: sedatsuridiinia tai tämän farmaseuttisesti hyväksyttävää suolaa; ja desitabiinia. | |
| NO2018029I1 (no) | Alogliptin i kombinasjon med metformin, hver eventuelt i form av et farmasøytisk akseptabelt salt derav | |
| IL193702A (en) | Pharmaceutical preparation containing human embryonic stem cells, methods of manufacture and use thereof | |
| EP2395834A4 (en) | Sodium nitrite-containing pharmaceutical compositions | |
| CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
| NO2017002I1 (no) | Cobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav, spesielt atazanavirsulfat | |
| NO20091501L (no) | Farmasoytiske sammensetninger | |
| JP2007527914A5 (enExample) | ||
| HUE064677T2 (hu) | Citidin-analógokat tartalmazó orális készítmények és eljárások azok alkalmazására | |
| IL190137A0 (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
| EP1991218A4 (en) | USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES | |
| DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
| JP2009536652A5 (enExample) | ||
| ZA200800408B (en) | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | |
| CL2013002905A1 (es) | Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares. | |
| CL2007000680A1 (es) | Compuesto cristalino (5s)-5-[4(cloro-piridin-2-iloxi)-piperidin-1-sulfonilmetil]-5-metil-imidazolidin-2,4-diona, forma g; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de epoc. | |
| HUE046349T2 (hu) | Kompozíciók rákos sejtek kezelésére, és ezek szintézise | |
| AR065342A1 (es) | Composiciones farmaceuticas que contienen fumarato de quetiapina | |
| EP2168584A4 (en) | PHARMACEUTICAL COMPOSITION COMBINING TRIAZOLOBENZODIAZEPINE AND SELECTIVE SEROTONIN RECAPTURE SELECTIVE INHIBITOR | |
| AP2413A (en) | 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other disease. | |
| JP2008531710A5 (enExample) | ||
| ZA200802774B (en) | Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake | |
| JP2008536808A5 (enExample) | ||
| GB0620695D0 (en) | Composition and methods for the treatment of nurdegenerative disease |